Sandoz Group (SDZNY) News Today → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free SDZNY Stock Alerts $35.76 +0.17 (+0.48%) (As of 06/7/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | marketwatch.comSandoz Gets European Marketing Approval for Osteoporosis, Bone Disease TreatmentsMay 22, 2024 | globenewswire.comSandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in EuropeMay 15, 2024 | reuters.comEx-Sandoz exec gets probation for price-fixing after cooperation dealMay 7, 2024 | markets.businessinsider.comBiosimilars Boosts Sandoz Q1 Sales; Backs Annual Sales OutlookMay 7, 2024 | globenewswire.comSandoz reports first quarter 2024 salesMay 2, 2024 | msn.comSandoz Group AG goes ex dividend tomorrowApril 30, 2024 | marketwatch.comSandoz Reaches Agreement With Amgen Resolving All Patent LitigationApril 30, 2024 | msn.comSandoz, Amgen reach agreement resolving patent litigation over biosimilarsApril 30, 2024 | globenewswire.comShareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGApril 30, 2024 | reuters.comSandoz reaches agreement with Amgen over patent disputeApril 30, 2024 | globenewswire.comSandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilarsApril 29, 2024 | msn.comAmgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelledApril 22, 2024 | markets.businessinsider.comSandoz : Pyzchiva Approved In Europe For Gastroenterology, Dermatology, And Rheumatology TreatmentsApril 22, 2024 | globenewswire.comSandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offeringMarch 21, 2024 | globenewswire.comSandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicinesMarch 14, 2024 | msn.comSandoz Group Non-GAAP EPS of $2.20, revenue of $9.65B; initiates FY24 and long-term outlookMarch 13, 2024 | theglobeandmail.comThe Cultivated B Introduces n!Biomachines: Fit-For-Purpose Bioreactors Designed to Easily and Affordably Scale Cellular AgricultureMarch 13, 2024 | globenewswire.comSandoz reports fourth quarter 2023 sales and full-year 2023 resultsMarch 6, 2024 | finanznachrichten.deSandoz Group: Sandoz receives FDA approval for first and only denosumab biosimilarsMarch 5, 2024 | globenewswire.comSandoz receives FDA approval for first and only denosumab biosimilarsMarch 5, 2024 | finanznachrichten.deSandoz Group: Sandoz announces nominations to the Board of Directors and leadership changeMarch 5, 2024 | finance.yahoo.comSandoz announces nominations to the Board of Directors and leadership changeMarch 5, 2024 | globenewswire.comSandoz announces nominations to the Board of Directors and leadership changeMarch 4, 2024 | globenewswire.comSandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US marketFebruary 29, 2024 | msn.comGeneric/Biosimilar Player Sandoz Settles US Price Fixing Case For $265MFebruary 29, 2024 | finanznachrichten.deSandoz Group: Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffsFebruary 29, 2024 | money.usnews.comSandoz Enters $265 Million Settlement Agreement in U.S. Price-Fixing CaseFebruary 29, 2024 | markets.businessinsider.comSandoz US Settles Antitrust Class Action Litigation With Direct Purchaser Class Plaintiffs February 29, 2024 | reuters.comSandoz enters $265 mln settlement agreement in U.S. price-fixing caseFebruary 29, 2024 | globenewswire.comSandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffsFebruary 20, 2024 | finance.yahoo.comSandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosisFebruary 1, 2024 | finance.yahoo.comSandoz announces changes in the Board of DirectorsJanuary 29, 2024 | marketbeat.comSandoz Group AG (OTCMKTS:SDZNY) Sees Large Increase in Short InterestSandoz Group AG (OTCMKTS:SDZNY - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 2,622,500 shares, a growth of 21.8% from the December 31st total of 2,152,900 shares. Based on an average trading volume of 302,400 shares, the short-interest ratio is presently 8.7 days.January 22, 2024 | finanznachrichten.deSandoz Group: Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US marketJanuary 22, 2024 | finance.yahoo.comSandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US marketNovember 27, 2023 | finance.yahoo.comSandoz Canada announces first ever list of Top 100 most important medicines, from a clinical standpoint, for Canadian patientsNovember 21, 2023 | markets.businessinsider.comSandoz Unveils Hyrimoz Citrate-free High Concentration Formulation In EuropeNovember 21, 2023 | finance.yahoo.comSandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe, aiming to improve patient careNovember 15, 2023 | wsj.comSandoz Group AG ADRNovember 11, 2023 | seekingalpha.comSandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028November 10, 2023 | finanznachrichten.deSandoz Group: Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in GermanyNovember 10, 2023 | finance.yahoo.comSandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in GermanyNovember 8, 2023 | finance.yahoo.comSandoz successfully issues EUR 2.0 billion inaugural EurobondsNovember 8, 2023 | finanznachrichten.deSandoz Group: Sandoz successfully issues EUR 2.0 billion inaugural EurobondsNovember 1, 2023 | morningstar.comSandoz Group AG ADR SDZNYOctober 29, 2023 | au.finance.yahoo.comSandoz Group AG (SDZNY)October 26, 2023 | finanznachrichten.deSandoz Group: Sandoz successfully issues CHF 750 million in inaugural bondsOctober 26, 2023 | finance.yahoo.comSandoz successfully issues CHF 750 million in inaugural bondsOctober 24, 2023 | markets.businessinsider.comSandoz 9-month Net Sales Up 6% In CC - Quick FactsOctober 24, 2023 | finance.yahoo.comSandoz reports year-to-date sales for the first nine months of 2023 Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution SDZNY Media Mentions By Week SDZNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDZNY News Sentiment▼0.000.76▲Average Medical News Sentiment SDZNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDZNY Articles This Week▼01▲SDZNY Articles Average Week Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KDDIY News BMWYY News BAESY News BCMXY News OLCLY News CMPGY News DNZOY News GVDNY News EXPGY News HOCPY News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDZNY) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredThe Most Dangerous Time for 401k OwnersThe world's most powerful CEO just issued a grave warning to Americans... "This may be the most dangerous t...Birch Gold | Sponsored